From today, thousands more Australians living with advanced and rare cancers will have access to affordable immunotherapy treatment options through ...
Alexion, AstraZeneca Rare Disease's Ultomiris® (ravulizumab rch) has been listed on the Pharmaceutical Benefits Scheme (PBS) for adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results